2025 University of Kansas Cancer Center Breast Cancer Year in Review
Learn How to Claim Your Credit
The University of Kansas Cancer Center Breast Cancer Year in Review is a condensed review of new data and advances published throughout the year and presented at key oncology meetings. It gives healthcare providers the opportunity to learn about the latest advances in oncology education and translate science into better patient care. This accredited meeting is hosted as an in-person conference only with on-demand access for registered attendees
Accreditation Information | 4.00
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
-
Amedco LLC designates this activity for a maximum of 4.00 ANCC contact hours.
-
Amedco LLC designates this live activity for a maximum of 4.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
-
Amedco LLC designates this activity for a maximum of 4.00 knowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.
-
Name
Commercial Interest:Relationship
Kristy Brown NA
Erin Cobain
AstraZeneca, Pfizer, Novartis, Gilead, Daiichi Sankyo:Consultant
Epic Sciences, Novartis:Research Grant Overall Principal Investigator
Angela DeMichele NA
Ana Garrido-Castro
Gilead Sciences, Merck, AstraZeneca, Daiichi-Sankyo:Research Grant Overall
Principal Investigator
Zenith Epigenetics, Bristol-Myers Squibb, Novartis, Biovica, Foundation Medicine,
4D Path, Precede Biosciences:Research Grant Site Principal Investigator
Roche/Genentech:Other
Matthew Goetz
Consulting fees to Mayo Clinic from AstraZeneca, AstraZeneca UK Ltd, BeiGene
USA, Biotheranostics, , Consulting fees to Mayo Clinic from Biotheryx,
eChinaHealth, EcoR1, Lilly, Engage Health Media, Genentech, Incyclix, Laekna,
Novartis, RNA Diagnostics, Consulting fees to Mayo Clinic from Sermonix, Stemline
Therapeutics, TerSera Therapeutics:Scientific/Medical Advisory Board Member
Grant funding to Mayo Clinic from AstraZeneca, ATOSSA Therapeutics, Biotheryx,
Lilly, LOXO, Pfizer, Sermonix, SimBioSys:Research Grant Site Principal Investigator
personal fees for CME activities from AXIS, BroadcastMed, DAVA Oncology,
IDEOlogy Health, MJH Life Sciences, PeerView, Physicians' Education Resource,
Total Health Conferencing:Consultant
Jennifer Klemp
National Cancer Institute:Research Grant Overall Principal Investigator
Pfizer:Speakers Bureau
Cancer Survivorship Training, Inc:Stock Shareholder
Cancer Resource Partners, LLC:Principal
University of Kansas Cancer Center, Caris Lifesciences:Employee
Pavan Reddy NA
priyanka sharma
Merck , Novartis , Astra Zeneca , Gilead , Pfizer :Scientific/Medical Advisory Board
Member
Shane Stecklein NA
Julia White NA
Kari Wisinski
Gilead, Pfizer, Novartis, AstraZeneca:Other
Puma, Relay, Genentech/Roche, Jazz, Sanofi, Seagen:Research Grant Site
Principal Investigator
Loxo@Lilly, Stemline Therapeutics:Scientific/Medical Advisory Board Member
Reyna Wilhelm NA
Justin Kaiser NA
How to Get Your Certificate
Go to thc.cmecertificateonline.com
Evaluate the meeting.
Print, download, or save your certificate for your records.
If you lose your certificate, or need help, go to help.cmecertificateonline.com